Bausch Lomb Corp stock is traded at $19.38, with a volume of 848,422. It is down -6.33% in the last 24 hours and up +14.47% over the past month. Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Previous Close:
$20.69
Open:
$20.24
24h Volume:
848,422
Relative Volume:
1.16
Market Cap:
$6.93B
Revenue:
$5.21B
Net Income/Loss:
-$211.00M
P/E Ratio:
-
EPS:
-$0.6179
Net Cash Flow:
$861.30K
1W Performance:
-8.11%
1M Performance:
+14.47%
6M Performance:
+19.63%
1Y Performance:
+33.10%
1-Day Range:
$19.30$20.50
1-Week Range:
$19.30$21.37
52-Week Range:
$14.44$21.40
Bausch Lomb Corp Stock (BLCO) Company Profile
Name
Bausch Lomb CorpSector
HealthcareIndustry
Medical Instruments & SuppliesPhone
908-541-5456Address
520 APPLEWOOD CRESCENT, VAUGHAN, CanadaMarket Cap
Revenue
Net Income
Cash Flow
EPS